Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Midatech Pharma ADR
(NQ:
MTP
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EDT, Mar 24, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Midatech Pharma ADR
< Previous
1
2
Next >
Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease
March 27, 2023
Via
ACCESSWIRE
Midatech Pharma PLC Announces Results of General Meeting
March 24, 2023
Via
ACCESSWIRE
Midatech Pharma PLC Announces Further re: Notice of General Meeting
March 10, 2023
Via
ACCESSWIRE
Midatech Pharma PLC Announces Posting of Circular and Notice of General Meeting
March 08, 2023
Via
ACCESSWIRE
Midatech Pharma PLC Announces Closing of $6.0m Private Placement & Broker Change
February 15, 2023
Via
ACCESSWIRE
Midatech Pharma PLC Announces Private Placement Raising US $6.0 million
February 09, 2023
Via
ACCESSWIRE
Midatech Pharma PLC Announces Result of General Meeting
January 23, 2023
Via
ACCESSWIRE
Midatech Pharma PLC Announces Planned Dose Escalation in MTX-110 Phase 1 Study
January 12, 2023
Via
ACCESSWIRE
Midatech Pharma PLC Announces Posting of Circular and Notice of General Meeting
January 06, 2023
Via
ACCESSWIRE
Midatech Pharma PLC - First Patient Enrolled in Phase 1 Study of MTX-110
November 14, 2022
Via
ACCESSWIRE
Midatech Pharma PLC Announces Receipt of NASDAQ Notice
February 03, 2023
Via
ACCESSWIRE
Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders
January 11, 2023
From
Bioasis Technologies Inc.
Via
GlobeNewswire
Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc
December 19, 2022
From
Bioasis Technologies Inc.
Via
GlobeNewswire
Midatech Pharma PLC Announces Closing of Offering, Revised Terms, AIM & Webinar
December 19, 2022
Via
ACCESSWIRE
Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc
December 13, 2022
US$10M Registered Direct Offering and PIPE to Strengthen Balance Sheet of Combined Company
From
Bioasis Technologies Inc.
Via
GlobeNewswire
Midatech Pharma PLC Announces Proposed Acquisition of Bioasis Technologies Inc
December 13, 2022
Via
ACCESSWIRE
Midatech Pharma PLC Announces Receipt of NASDAQ Notification
October 18, 2022
Via
ACCESSWIRE
Midatech Pharma PLC Announces ADR Ratio Change
September 14, 2022
Via
ACCESSWIRE
Midatech Pharma PLC Announces Interim Results for the Six Months to 30 June 2022
September 14, 2022
Via
ACCESSWIRE
Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma
June 21, 2022
Orphan Designation Granted by EMA to MTX110 Development for the Treatment of Glioma
From
Midatech Pharma PLC
Via
AccessWire
Midatech Pharma PLC Announces Retirement of Chairman and Proposed New Chairman
June 10, 2022
ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines,...
From
Midatech Pharma PLC
Via
AccessWire
Topics
Retirement
Exposures
Pension
Midatech Pharma PLC - MTX110 Study to be Presented at ISPNO 2022
June 10, 2022
ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines,...
From
Midatech Pharma PLC
Via
AccessWire
Midatech Pharma PLC Announces Fast Track Designation for MTX110 Development
June 01, 2022
Fast Track Designation Granted to MTX110 Development for the Treatment of Recurrent Glioblastoma
From
Midatech Pharma PLC
Via
AccessWire
Exposures
Product Safety
Midatech Pharma PLC Announces Posting of Annual Report & Notice of AGM
May 24, 2022
ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 24, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of...
From
Midatech Pharma PLC
Via
AccessWire
Midatech Pharma PLC Announces Results for the Year Ended 31 December 2021
April 26, 2022
ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 26, 2022 / Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines,...
From
Midatech Pharma PLC
Via
AccessWire
Midatech Pharma PLC Announces Receipt of NASDAQ Notice
April 14, 2022
ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 14, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of...
From
Midatech Pharma PLC
Via
AccessWire
Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule
March 09, 2022
ABINGDON, UK / ACCESSWIRE / March 9, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is...
From
Midatech Pharma PLC
Via
AccessWire
Midatech Pharma PLC Announces Appointment of Nominated and Financial Adviser
March 08, 2022
ABINGDON, UK / ACCESSWIRE / March 8, 2022 / Midatech Pharma PLC (AIM:MTPH; NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicine, is...
From
Midatech Pharma PLC
Via
AccessWire
Midatech Pharma PLC Announces IND Application for MTX110 Study in GBM Effective
December 13, 2021
Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective ABINGDON, OXFORDSHIRE / ACCESSWIRE / December 13, 2021 / Midatech Pharma PLC...
From
Midatech Pharma PLC
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Midatech Pharma PLC Announces Notice of Interim Results
September 06, 2021
ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 6, 2021 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of...
From
Midatech Pharma PLC
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit